Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients

BACKGROUND: Immune checkpoint blockade has emerged as a highly effective treatment for patients with metastatic melanoma and cutaneous squamous cell carcinoma. Nivolumab blocks the interactions between programmed cell death protein 1 and programmed death ligand 1 allowing for activation of a latent...

Descripción completa

Detalles Bibliográficos
Autores principales: Trager, Megan H, Coley, Shana M, Dube, Geoffrey, Khan, Shaheer, Ingham, Matthew, Samie, Faramarz H, Geskin, Larisa J, McDonnell, Diana, Brouder, Daniel, Saenger, Yvonne, Carvajal, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279669/
https://www.ncbi.nlm.nih.gov/pubmed/32503950
http://dx.doi.org/10.1136/jitc-2020-000908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279669/
https://www.ncbi.nlm.nih.gov/pubmed/32503950
http://dx.doi.org/10.1136/jitc-2020-000908

Ejemplares similares